Invention Grant
- Patent Title: KATP antagonists (glibenglamid) for use for promoting growth and/or treating hyperglycaemia of a premature infant
-
Application No.: US14115103Application Date: 2012-05-02
-
Publication No.: US10307430B2Publication Date: 2019-06-04
- Inventor: Michel Polak , Marianne Berdugo Polak
- Applicant: Michel Polak , Marianne Berdugo Polak
- Applicant Address: FR Paris
- Assignee: ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
- Current Assignee: ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
- Current Assignee Address: FR Paris
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP11305520 20110503
- International Application: PCT/EP2012/057995 WO 20120502
- International Announcement: WO2012/150245 WO 20121108
- Main IPC: A61K31/64
- IPC: A61K31/64 ; A61K31/451 ; A61K9/00
Abstract:
The present invention relates to pharmaceutical compositions comprising an ATP-sensitive potassium (K ATP) channel antagonist (e.g., sulfonylureas, meglitinides) and methods for treating hyperglycaemia and/or promoting growth of a premature and/or small for gestational age infant.
Public/Granted literature
Information query
